Gene · 5590
Papers4,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway. | Clin Transl Med | 2023 | 37965796 | PubTator, text mining | PubMed |
| Deletion in 1p36.33-p36.32 is associated with pancytopenia: a case report. | BMC Med Genomics | 2023 | 37946214 | PubTator, text mining | PubMed |
| Multi-scale characterisation of homologous recombination deficiency in breast cancer. | Genome Med | 2023 | 37919776 | PubTator, text mining | PubMed |
| Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol. | Front Immunol | 2023 | 37901225 | PubTator, text mining | PubMed |
| PKCζ phosphorylates VASP to mediate chemotaxis in breast cancer cells. | Exp Cell Res | 2023 | 37890607 | PubTator, text mining | PubMed |
| Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease. | Nat Commun | 2023 | 37872160 | PubTator, text mining | PubMed |
| Sphingolipid metabolism in brain insulin resistance and neurological diseases. | Front Endocrinol (Lausanne) | 2023 | 37867511 | PubTator, text mining | PubMed |
| From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress. | Signal Transduct Target Ther | 2023 | 37857607 | PubTator, text mining | PubMed |
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome. | Front Psychiatry | 2023 | 37854446 | PubTator, text mining | PubMed |
| Morphogenesis and development of human telencephalic organoids in the absence and presence of exogenous extracellular matrix. | EMBO J | 2023 | 37842725 | PubTator, text mining | PubMed |
| Privacy and ethical challenges of the Amelogenin sex test in forensic paternity/kinship analysis: Insights from a 13-year case history. | Forensic Sci Int Synerg | 2023 | 37840559 | PubTator, text mining | PubMed |
| Occludin: a gatekeeper of brain Infection by HIV-1. | Fluids Barriers CNS | 2023 | 37840143 | PubTator, text mining | PubMed |
| c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease. | BMC Med Genomics | 2023 | 37833700 | PubTator, text mining | PubMed |
| The Antitumor Activity of Piplartine: A Review. | Pharmaceuticals (Basel) | 2023 | 37765054 | PubTator, text mining | PubMed |
| A Unique G-Quadruplex Aptamer: A Novel Approach for Cancer Cell Recognition, Cell Membrane Visualization, and RSV Infection Detection. | Int J Mol Sci | 2023 | 37762645 | PubTator, text mining | PubMed |
| Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications. | Int J Mol Sci | 2023 | 37762318 | PubTator, text mining | PubMed |
| Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment. | Cancer Manag Res | 2023 | 37693221 | PubTator, text mining | PubMed |
| Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis? | Int J Mol Sci | 2023 | 37686269 | PubTator, text mining | PubMed |
| The biased M3 mAChR ligand PD 102807 mediates qualitatively distinct signaling to regulate airway smooth muscle phenotype. | J Biol Chem | 2023 | 37660916 | PubTator, text mining | PubMed |
| Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes. | J Lipid Res | 2023 | 37640282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5590/papers?page=8